Strengthening Families Living With HIV in Kenya

  • End date
    Feb 25, 2025
  • participants needed
  • sponsor
    The University of Texas Medical Branch, Galveston
Updated on 19 July 2021
HIV Vaccine


This study seeks to use a group-based microfinance/internal lending model to develop social capital among people with HIV in Kenya. This will create a context to deliver validated curriculum targeting intimate partner violence, positive parenting, agriculture, small business entrepreneurship, group-interpersonal therapy, and other determinants of well-being and ART adherence among people with HIV. The primary outcomes are viral suppression, ART adherence, and common mental disorders.


It is anticipated that involvement in an internal savings and lending program will create social capital among people with HIV and their guardians (in case of adolescents w HIV). This social capital accrual will be leveraged to support and disseminate social skills (i.e. positive parenting, conflict resolution), economic skills (i.e. entrepreneurship, farming), and health skills (i.e. ART adherence, retention in care to produce viral suppression). The overall outcome is improved social, health, and economic well-being.

Condition assisted reproductive technology, HIV, HIV positive, HIV infection, AIDS Vaccines, Trust, Noncompliance with medication regimen, Arts, Post-Traumatic Stress Disorder, Antiretroviral Therapy, Artesunate, HIV Infections, PTSD, anxiety/depression, human immunodeficiency virus, hiv disease, assisted reproductive technologies, anti-retroviral therapy, HIV Vaccine, hiv vaccines
Treatment Kuja Pamoja - HIV
Clinical Study IdentifierNCT04588883
SponsorThe University of Texas Medical Branch, Galveston
Last Modified on19 July 2021


Yes No Not Sure

Inclusion Criteria

Criteria for inclusion of subjects include
testing positive for HIV, confirmed by the Ministry of Health clinics
being at or older than 13 years of age
initiating care at a qualified Ministry of Health clinic in the catchment area, or intending to initiate care at such a clinic (see below for definition)
Any gender, age (13+ years), and comorbid disease states
Provide informed consent if adult, emancipated minor or mature minor
Provide assent if minor with guardian, who must provide informed consent
Qualified clinical locations include
those with accessible and usable public land to convene weekly meetings
no current program targeting families with HIV known to the Ministry of Health

Exclusion Criteria

Refusal to participate
Current participation in a similar program
Residing in a location with a similar program targeting patients with HIV
Not covered by inclusion criteria
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note